Farwell Wildon

CIK 00018479411 companyWALTHAM, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001847941

Recent Transactions

31 trades

Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-08-19$46.00/sh−261→ 143,222 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-08-19$45.01/sh−2,060→ 143,483 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-06-11$31.27/sh−1,008→ 145,543 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-06-11$31.27/sh−1,628→ 146,551 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-05-16$28.59/sh−425→ 148,179 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-05-16$28.20/sh−1,956→ 148,604 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-03-12$25.58/sh−1,030→ 150,560 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-03-11$25.70/sh−1,585→ 151,590 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-03-07$25.80/sh−8,364→ 154,732 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-03-07$26.20/sh−1,557→ 153,175 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-02-28$25.00/sh−407→ 163,096 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-02-12$25.07/sh−5,493→ 163,503 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-01-26$25.00/sh−100→ 168,996 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2023-12-12$10.55/sh−978→ 169,096 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2023-12-11$10.72/sh−1,688→ 170,074 total
Award
Dyne Therapeutics, Inc.$DYN
Stock Option (right to buy)
2023-11-15+32,131→ 32,131 total
Award
Dyne Therapeutics, Inc.$DYN
Common Stock
2023-11-15+82,512→ 171,762 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2023-09-12$10.41/sh−1,707→ 89,250 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2023-06-13$12.43/sh−1,698→ 90,957 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2023-03-14$13.33/sh−7,441→ 92,655 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2022-12-12$10.87/sh−628→ 100,096 total
Award
Dyne Therapeutics, Inc.$DYN
Common Stock
2022-12-09+36,000→ 100,724 total
Award
Dyne Therapeutics, Inc.$DYN
Stock option (right to buy)
2022-12-09+56,000→ 56,000 total
Disposition to Issuer
Dyne Therapeutics, Inc.$DYN
Common Stock
2022-09-15$14.05/sh−658→ 64,724 total
Disposition to Issuer
Dyne Therapeutics, Inc.$DYN
Common Stock
2022-06-14$4.95/sh−668→ 65,382 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2022-03-11$8.73/sh−640→ 66,050 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2022-03-02$8.56/sh−5,617→ 66,690 total
Award
Dyne Therapeutics, Inc.$DYN
Common Stock
2021-12-10+22,307→ 72,307 total
Award
Dyne Therapeutics, Inc.$DYN
Stock Option (right to buy)
2021-12-10+67,935→ 67,935 total
Award
Dyne Therapeutics, Inc.$DYN
Common Stock
2021-03-02+50,000→ 50,000 total
Award
Dyne Therapeutics, Inc.$DYN
Stock Option (right to buy)
2021-03-02+250,000→ 250,000 total

Companies

Dyne Therapeutics, Inc.
Chief Medical Officer
$DYN

Recent Filings

Address

C/O DYNE THERAPEUTICS, INC. 830 WINTER STREET

WALTHAM, MA, 02451

View on SEC.gov